260 related articles for article (PubMed ID: 19427778)
1. Docosahexaenoic acid down-regulates phenobarbital-induced cytochrome P450 2B1 gene expression in rat primary hepatocytes via the sphingomyelinase/ceramide pathway.
Lu CY; Li CC; Liu KL; Tsai CW; Lii CK; Chen HW
J Nutr Biochem; 2010 Apr; 21(4):338-44. PubMed ID: 19427778
[TBL] [Abstract][Full Text] [Related]
2. n-6 and n-3 polyunsaturated fatty acids down-regulate cytochrome P-450 2B1 gene expression induced by phenobarbital in primary rat hepatocytes.
Li CC; Lii CK; Liu KL; Yang JJ; Chen HW
J Nutr Biochem; 2006 Oct; 17(10):707-15. PubMed ID: 16517146
[TBL] [Abstract][Full Text] [Related]
3. Docosahexaenoic acid downregulates phenobarbital-induced cytochrome P450 2B1 gene expression in rat primary hepatocytes via the c-Jun NH2-terminal kinase mitogen-activated protein kinase pathway.
Lu CY; Li CC; Liu KL; Lii CK; Chen HW
Mol Nutr Food Res; 2009 Mar; 53(3):341-8. PubMed ID: 18803253
[TBL] [Abstract][Full Text] [Related]
4. DHA down-regulates phenobarbital-induced cytochrome P450 2B1 gene expression in rat primary hepatocytes by attenuating CAR translocation.
Li CC; Lii CK; Liu KL; Yang JJ; Chen HW
Toxicol Appl Pharmacol; 2007 Dec; 225(3):329-36. PubMed ID: 17904175
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E2 down-regulation of cytochrome P-450 2B1 expression induced by phenobarbital is through EP2 receptor in rat hepatocytes.
Li CC; Shen HL; Lii CK; Liu KL; Yang JJ; Chen HW
Biochem Biophys Res Commun; 2005 Feb; 327(2):424-30. PubMed ID: 15629132
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E2 is involved in the increase of cytochrome P-450 2B1 expression by alpha-tocopheryl succinate in primary rat hepatocytes in the presence of phenobarbital.
Tsai CF; Lii CK; Yang JJ; Liu K; Lin WL; Chen HW
Nutr Cancer; 2001; 41(1-2):188-95. PubMed ID: 12094624
[TBL] [Abstract][Full Text] [Related]
7. Critical role of extracellular matrix on induction by phenobarbital of cytochrome P450 2B1/2 in primary cultures of adult rat hepatocytes.
Brown SE; Guzelian CP; Schuetz E; Quattrochi LC; Kleinman HK; Guzelian PS
Lab Invest; 1995 Dec; 73(6):818-27. PubMed ID: 8558843
[TBL] [Abstract][Full Text] [Related]
8. Involvement of cyclic nucleotide- and calcium-regulated pathways in phenobarbital-induced cytochrome P-450 3A expression in mouse primary hepatocytes.
Galisteo M; Marc N; Fautrel A; Guillouzo A; Corcos L; Lagadic-Gossmann D
J Pharmacol Exp Ther; 1999 Sep; 290(3):1270-7. PubMed ID: 10454503
[TBL] [Abstract][Full Text] [Related]
9. Homocysteine activates cAMP-response element binding protein in HepG2 through cAMP/PKA signaling pathway.
Woo CW; Siow YL; O K
Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1043-50. PubMed ID: 16497994
[TBL] [Abstract][Full Text] [Related]
10. Opposite regulation of the mitochondrial apoptotic pathway by C2-ceramide and PACAP through a MAP-kinase-dependent mechanism in cerebellar granule cells.
Falluel-Morel A; Aubert N; Vaudry D; Basille M; Fontaine M; Fournier A; Vaudry H; Gonzalez BJ
J Neurochem; 2004 Dec; 91(5):1231-43. PubMed ID: 15569266
[TBL] [Abstract][Full Text] [Related]
11. Regulation of phenobarbital-inducible cytochrome P450 2B1/2 mRNA by lovastatin and oxysterols in primary cultures of adult rat hepatocytes.
Kocarek TA; Schuetz EG; Guzelian PS
Toxicol Appl Pharmacol; 1993 Jun; 120(2):298-307. PubMed ID: 8511800
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-1beta-induced apoptosis through adenylyl cyclase and ERK1/2 inhibition in primary cultured thyroid cells.
El Btaouri H; Rath G; Morjani H; Schneider C; Petitfrere E; Antonicelli F; Martiny L
Biochem Biophys Res Commun; 2006 Jan; 339(2):469-76. PubMed ID: 16310170
[TBL] [Abstract][Full Text] [Related]
13. PACAP and C2-ceramide generate different AP-1 complexes through a MAP-kinase-dependent pathway: involvement of c-Fos in PACAP-induced Bcl-2 expression.
Aubert N; Falluel-Morel A; Vaudry D; Xifro X; Rodriguez-Alvarez J; Fisch C; de Jouffrey S; Lebigot JF; Fournier A; Vaudry H; Gonzalez BJ
J Neurochem; 2006 Nov; 99(4):1237-50. PubMed ID: 17026529
[TBL] [Abstract][Full Text] [Related]
14. Pituitary adenylate cyclase-activating polypeptide prevents C2-ceramide-induced apoptosis of cerebellar granule cells.
Vaudry D; Falluel-Morel A; Basille M; Pamantung TF; Fontaine M; Fournier A; Vaudry H; Gonzalez BJ
J Neurosci Res; 2003 May; 72(3):303-16. PubMed ID: 12692897
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1 beta stimulates sphingomyelin hydrolysis in cultured granulosa cells: evidence for a regulatory role of ceramide on progesterone and prostaglandin biosynthesis.
Santana P; Llanes L; Hernandez I; Gonzalez-Robayna I; Tabraue C; Gonzalez-Reyes J; Quintana J; Estevez F; Ruiz de Galarreta CM; Fanjul LF
Endocrinology; 1996 Jun; 137(6):2480-9. PubMed ID: 8641202
[TBL] [Abstract][Full Text] [Related]
16. Sphingomyelinase inhibits in vitro Leydig cell function.
Degnan BM; Bourdelat-Parks B; Daniel A; Salata K; Francis GL
Ann Clin Lab Sci; 1996; 26(3):234-42. PubMed ID: 8726216
[TBL] [Abstract][Full Text] [Related]
17. Acid sphingomyelinase activation requires caspase-8 but not p53 nor reactive oxygen species during Fas-induced apoptosis in human glioma cells.
Sawada M; Nakashima S; Kiyono T; Yamada J; Hara S; Nakagawa M; Shinoda J; Sakai N
Exp Cell Res; 2002 Feb; 273(2):157-68. PubMed ID: 11822871
[TBL] [Abstract][Full Text] [Related]
18. TNFR1-induced sphingomyelinase activation modulates TCR signaling by impairing store-operated Ca2+ influx.
Church LD; Hessler G; Goodall JE; Rider DA; Workman CJ; Vignali DA; Bacon PA; Gulbins E; Young SP
J Leukoc Biol; 2005 Jul; 78(1):266-78. PubMed ID: 15817701
[TBL] [Abstract][Full Text] [Related]
19. Phenobarbital induction of CYP2B1/2 in primary hepatocytes: endocrine regulation and evidence for a single pathway for multiple inducers.
Ganem LG; Trottier E; Anderson A; Jefcoate CR
Toxicol Appl Pharmacol; 1999 Feb; 155(1):32-42. PubMed ID: 10036216
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional regulation of CYP2B1 induction in primary rat hepatocyte cultures: repression by epidermal growth factor is mediated via a distal enhancer region.
Bauer D; Wolfram N; Kahl GF; Hirsch-Ernst KI
Mol Pharmacol; 2004 Jan; 65(1):172-80. PubMed ID: 14722249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
